Yahoo
NYSE - Nasdaq Real Time Price USD

The Procter & Gamble Company (PG)

159.06 +0.80 (+0.51%)
As of 10:08:35 AM EDT. Market Open.
Trade PG on Coinbase
Chart Range Bar
Loading chart for PG

What's happening with PG?

7m ago
Powered by Yahoo Scout

Procter & Gamble's latest quarter showed stronger volume and organic sales, but rising commodity, freight, currency, and restructuring costs are pressuring margins. Management maintained fiscal 2027 core EPS guidance while investors assess whether premium products and productivity savings can offset those headwinds. The company also issued new euro- and dollar-denominated notes, adding fresh information about its financing strategy.

Powered by Yahoo Scout
  • Previous Close 158.26
  • Open 160.09
  • Bid 158.90 x 20000
  • Ask 158.92 x 20000
  • Day's Range 158.68 - 160.95
  • 52 Week Range 137.62 - 167.25
  • Volume 1,302,532
  • Avg. Volume 9,017,678
  • Market Cap (intraday) 368.667B
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) 23.95
  • EPS (TTM) 6.64
  • Earnings Date (est.) Jan 21, 2027
  • Forward Dividend & Yield 4.35 (2.75%)
  • 1y Target Est 173.30
  • Morningstar Rating Rating available with Stock Picks access

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. It sells its products through mass merchandisers, social ecommerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The company was founded in 1837 and is headquartered in Cincinnati, Ohio.

www.pginvestor.com

104,000

Full Time Employees

June 30

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PG
14.21%
S&P 500 (^GSPC)
12.76%

1-Year Return

PG
10.02%
S&P 500 (^GSPC)
12.03%

3-Year Return

PG
17.00%
S&P 500 (^GSPC)
87.48%

5-Year Return

PG
26.54%
S&P 500 (^GSPC)
67.61%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 23.28B
Earnings 4.73B
Profit Margin 20.33%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
5B
10B
15B
20B
16.0%
18.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

143.00 Low
173.30 Average
159.06 Current
190.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/26/2026
Analyst Barclays
Rating Action Maintains
Rating Equal-Weight
Price Action Raises
Price Target 152 -> 165

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.23%

  • Return on Assets (ttm)

    10.49%

  • Return on Equity (ttm)

    29.61%

  • Revenue (ttm)

    87.92B

  • Net Income Avi to Common (ttm)

    15.74B

  • Diluted EPS (ttm)

    6.64

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.37B

  • Total Debt/Equity (mrq)

    70.34%

  • Levered Free Cash Flow (ttm)

    12.66B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: